Institute

Back to overview
Name

Institute of Oncology Research (IOR) Istituto Oncologico della Svizzera Italiana Università della Svizzera Italiana (USI)

Address Institute of Oncology Research (IOR) Istituto Oncologico della Svizzera Italiana Università della Svizzera Italiana (USI)
Via Chiesa, 5
6500
CH-Bellinzona
Show all

Projects

Responsible applicant Institution of higher education Start End date Funding scheme

Development of novel triterpenoid AMR-MeOAc based anti-KRas mutant pancreatic cancer chemotherapeutics
Thangaiyan Rabi Other Research Institutes - FINST 01.09.2014 30.11.2014 International short research visits

Molecular diagnosis of prostate cancer using cross-species comparison oncogenomics
Garcia-Escudero Ramon Other Research Institutes - FINST 01.07.2012 30.09.2012 International short research visits

The ETS transcription factor ESE3/EHF as a regulator of prostate epithelial cell differentiation and stem cell properties
Carbone Giuseppina Ente Ospedaliero Cantonale - EOC 01.04.2013 31.03.2016 Project funding

Steiner Trees for Functional Analysis in Cancer System Biology
Kwee Ivo Ente Ospedaliero Cantonale - EOC 01.09.2013 31.08.2017 Project funding

A novel combined approach of nuclear magnetic resonance (NMR) and Mass spectrometry to isolate the protein targets of chemical small molecules.
Gaudio Eugenio Non-profit organisations (libraries, museums, foundations) and administration - NPO 01.12.2019 31.12.2020 Spark

Small RNA-based transcriptional control of cancer genes: mechanisms and therapeutic applications
Catapano Carlo Ente Ospedaliero Cantonale - EOC 01.10.2009 30.09.2012 Project funding

Understanding Synthetic Sick Interactions of Prostate Cancer Driver Genes
Theurillat Jean-Philippe Università della Svizzera italiana - USI 01.09.2018 31.08.2020 SNSF Professorships

Characterization of specific enhancer RNAs involved in ibrutinib resistance mechanism in marginal zone lymphoma
Napoli Sara Università della Svizzera italiana - USI 01.03.2020 31.08.2021 Spark

Targeting metabolic reprogramming and plasticity of cancer stem cells to impact on tumor progression and treatment resistance
Catapano Carlo Ente Ospedaliero Cantonale - EOC 01.04.2017 31.03.2020 Project funding

Genetically-Induced Aberrant Chromatin States in Prostate Cancer - Biology and Therapy
Theurillat Jean-Philippe Università della Svizzera italiana - USI 01.09.2014 31.08.2018 SNSF Professorships

The ETS transcription factor ESE3/EHF as a regulator of prostate epithelial cell differentiation and stem cell properties
Carbone Giuseppina Ente Ospedaliero Cantonale - EOC 01.10.2016 30.09.2019 Project funding

Molecular prediction of long term benefit from ibrutinib in high risk chronic lymphocytic leukemia
Rossi Davide Ente Ospedaliero Cantonale - EOC 01.01.2017 31.12.2019 Project funding
-